[
    "{\"step_by_step_thinking\": \"To determine if vocimagene amiretrorepvec is effective for recurrent high-grade glioma, we need to review the available evidence. This can be done by looking at clinical trials and studies that have evaluated the use of vocimagene amiretrorepvec in patients with recurrent high-grade glioma. We should consider factors such as the study design, sample size, duration of follow-up, and the outcomes measured. By reviewing the evidence, we can determine if vocimagene amiretrorepvec has shown effectiveness in treating recurrent high-grade glioma.\", \"answer_choice\": \"B. no\"}"
]